Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies
Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies is a paper indexed in PICO Portal from OpenAlex.
How many citations does Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies have?
Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies has 274 citations in the OpenAlex counts PICO Portal stores.
When was Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies published?
Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies has 2017 year in the PICO Portal index.
What is the open-access status of Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies?
Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies has bronze oa status in the PICO Portal index.
What is the DOI of Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies?
The DOI for Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies is on the source record.
What is the PMID of Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies?
The PMID for Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies is on the source record.
What is the OpenAlex record for Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies?
The OpenAlex for Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies is on the source record.